BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gale RP, Armitage JO. Use of molecularly-cloned haematopoietic growth factors in persons exposed to acute high-dose, high-dose rate whole-body ionizing radiations. Blood Rev 2021;45:100690. [PMID: 32273121 DOI: 10.1016/j.blre.2020.100690] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Gale RP. Is there a role for haematopoietic cell transplants after radiation and nuclear accidents? J Radiol Prot 2021;41. [PMID: 33652427 DOI: 10.1088/1361-6498/abeb24] [Reference Citation Analysis]
2 Singh VK, Seed TM. Radiation countermeasures for hematopoietic acute radiation syndrome: growth factors, cytokines and beyond. Int J Radiat Biol 2021;:1-22. [PMID: 34402734 DOI: 10.1080/09553002.2021.1969054] [Reference Citation Analysis]
3 Lazarus HM, Gale RP. G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19? Acta Haematol 2021;144:355-9. [PMID: 32791509 DOI: 10.1159/000510352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
4 Yu X, Zhu L, Liang X, Yuan B, Li M, Hu S, Ding P, Du L, Guo J, Jin Y. A wearable gamma radiation-responsive granulocyte colony-stimulating factor microneedle system protecting against ionizing radiation-induced injury. Acta Biomater 2022;146:197-210. [PMID: 35487423 DOI: 10.1016/j.actbio.2022.04.040] [Reference Citation Analysis]
5 Chinnapaka S, Yang KS, Samadi Y, Epperly MW, Hou W, Greenberger JS, Ejaz A, Rubin JP. Allogeneic adipose-derived stem cells mitigate acute radiation syndrome by the rescue of damaged bone marrow cells from apoptosis. Stem Cells Transl Med 2021;10:1095-114. [PMID: 33724714 DOI: 10.1002/sctm.20-0455] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Singh VK, Fatanmi OO, Wise SY, Carpenter A, Nakamura-Peek S, Serebrenik AA, Kaytor MD. A novel oral formulation of BIO 300 confers prophylactic radioprotection from acute radiation syndrome in mice. Int J Radiat Biol 2021;:1-10. [PMID: 34554032 DOI: 10.1080/09553002.2021.1981556] [Reference Citation Analysis]
7 Lazarus HM, Ragsdale CE, Gale RP, Lyman GH. Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time? Front Immunol 2021;12:706186. [PMID: 34484202 DOI: 10.3389/fimmu.2021.706186] [Reference Citation Analysis]
8 Courtney CM, Sharma S, Fallgren C, Weil MM, Chatterjee A, Nagpal P. Reversing Radiation-Induced Immunosuppression Using a New Therapeutic Modality. Life Sciences in Space Research 2022. [DOI: 10.1016/j.lssr.2022.05.002] [Reference Citation Analysis]
9 Singh VK, Seed TM, Cheema AK. Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: current status and future perspectives. Expert Rev Mol Diagn 2021;21:641-54. [PMID: 34024238 DOI: 10.1080/14737159.2021.1933448] [Reference Citation Analysis]
10 Singh VK, Seed TM. Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure. Front Pharmacol 2021;12:624844. [PMID: 34040517 DOI: 10.3389/fphar.2021.624844] [Reference Citation Analysis]